Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous methylprednisolone for hearing preservation in cochlear implant surgery
ACTRN12619000120178Phase 2Completed
- Sponsor
- University of Melbourne
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylprednisolone in Hypoacusis (2 arms), sponsored by University of Melbourne. Primary endpoint: Preservation of hearing. Started Apr 2011; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Hypoacusis
Beyond the preview
Go deeper on ACTRN12619000120178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000120178.